Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine and Insulin in Psychosis: Imaging the Effects of Intranasal Insulin on Dopamine Transmission

NCT07252752 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT07252752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07252752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine and Insulin in Psychosis: Imaging the Effects of Intranasal Insulin on Dopamine Transmission
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
January 1, 2029
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

first episode psychosis (fep)